Glutamate Sample Clauses

Glutamate. Axo-axonic synapses are found in abundance on unmyelinated fibers (▇▇▇▇▇▇▇▇ 1990; ▇▇▇, Mantyh et al. 1997). Selective depolarization of C-fibers is seen upon exposure of these fibers to the ionotropic glutamate receptor agonist, kainate. As such, presynaptic 2-amino-3-(5-methyl-3- oxo-1, 2- oxazol-4-yl) propanoic acid (AMPA), kainite and N-methyl-D-aspartate receptors
Glutamate. It has become increasingly evident that in addition to dopamine, glutamate plays an essential role in drug reward and reinforcement. Dopaminergic neurons in the NAc and VTA receive extensive glutamatergic input from the PFC, amygdala and hippocampus 48,112,215,256,264,343,654. Cocaine and amphetamine both stimulate glutamate release in the PFC and NAc 540 which is potentiated with repeated exposure 539. Glutamate enhances dopaminergic transmission by increasing activ- ity of the dopaminergic neurons in the VTA, and facilitating dopamine release from the presynaptic terminals in the NAc 48,215,335,654. Many of the actions of the excitatory transmitter rely on this stimulatory interaction with the dopamine system. For example, basal and psychostimulant-induced locomotion, which are critically dependent on dopamine, are stimulated and inhibited by glutamatergic agonists and antagonists, respectively 534,650. However, as described below, some of the actions of the excitatory transmitter in psychostimulant reinforcement are independent of dopamine. Glutamate acts via two classes of receptors: ionotropic (ligand-gated ion ▇▇▇▇- ▇▇▇▇) and metabotropic (G-protein coupled) receptors, each consisting of multiple subtypes that may, depending on localisation and function, have distinct roles in drug reinforcement. During maintenance of cocaine self-administration, stimula- tion of ionotropic glutamate receptors in the NAc causes a leftward shift in the dose-response curve, whereas antagonism of these receptors is ineffective 128. The authors argue that signalling via ionotropic receptors in the NAc enhances cocaine reward whereas it is not required for maintenance of cocaine self-administration. Conversely, blockade of the metabotropic glutamate receptor 5 (mGluR5) reduces cocaine-maintained self-administration and the motivation to obtain the drug under a progressive ratio schedule, while elevating reward thresholds for intracranial self- stimulation 350,380,495,658. Furthermore, mice lacking the mGluR5 do not self-administer cocaine and do not show increased locomotion after cocaine administration, de- spite the fact that dopamine function is comparable to that of wild-type mice 105. These studies point to an important role for mGluR5 in cocaine reward, which may be independent of dopamine transmission. Glutamatergic transmission via ionotropic and metabotropic receptors modulates drug- and cue-induced reinstatement of cocaine seeking which is in good agree- ment wi...
Glutamate. This is the primary excitatory neurotransmitter in the brain. There are several types of ionotropic glutamate receptors, classified as NMDA (N-methyl-D-aspartate) and non- NMDA receptors (AMPA and Kainate). AMPA and kainate are permeable to sodium ions and mediate fast excitatory neuronal signalling. NMDA is only activated during prolonged depolarisation. The only medication currently with selective effects on glutamate is perampanel, which is an AMPA receptor antagonist. Blockade of the NMDA subtype of glutamate receptor is also believed to partly contribute to the pharmacological profile of felbamate and topiramate.

Related to Glutamate

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Vlastnictví Zdravotnické zařízení si ponechá a bude uchovávat Zdravotní záznamy. Zdravotnické zařízení a Zkoušející převedou na Zadavatele veškerá svá práva, nároky a tituly, včetně práv duševního vlastnictví k Důvěrným informacím (ve smyslu níže uvedeném) a k jakýmkoli jiným Studijním datům a údajům.

  • VOETSTOOTS The PROPERTY is sold: 8.1. Voetstoots in accordance with the Sectional Plan and the participation quota endorsed thereon with the opening of the Sectional Title Register, or as they are endorsed already, and any amendments or adjustments thereto from time to time in accordance with the terms of the Act and without any warranties express or implied, the SELLER shall not be liable for any patent or latent defects. Should the extent of the Section or of the PROPERTY differ from that which is contained in the title deed or sectional plan or any amendment thereto, the SELLER shall not be liable for any shortfall or be entitled to any compensation for any surplus. 8.2. Subject to all the conditions and Regulations of the Act. 8.3. The PURCHASER acknowledges that this is not a construction contract and that he is purchasing a completed unit. The PURCHASER shall not have the right to interfere in any way with the building operations of the SELLER’S employees. He shall also have no right to retention. This Clause is also applicable in the case of the bank holding back any retention amount out of its own accord or on request of the PURCHASER. 8.4. The SELLER undertakes to erect the unit according to the general building standards as set by Financial Institutions. The unit is be registered with the NHBRC. 8.5. Should a dispute arise or be declared, such dispute shall be resolved by an Arbitrator appointed by the Developer. The costs in respect thereof shall be borne by the unsuccessful party. Pending the outcome of the dispute, the PURCHASER shall be obliged to pay the outstanding amount to the Conveyancers who shall hold it in trust.

  • Publikace The Institution and the Investigator agree that the Sponsor shall have the sole and exclusive right to the first publication of the results of the Study. Such Sponsor publication is intended to be a multi-center publication of the Study results, collected from all investigators and institutions participating in the Study (the “Multi- Center Publication”). If the Investigator is interested in contributing to or participating in the Multi-Center Publication, he or she must contact the Sponsor. Selection of authors/participants will be governed by the Sponsor, considering individuals’ contribution to the Study.

  • Synchronous Generation The Interconnection Customer shall design its Small Generating Facility to maintain a composite power delivery at continuous rated power output at the Point of Interconnection at a power factor within the range of 0.95 leading to 0.95 lagging, unless the NYISO or the Transmission Owner in whose Transmission District the Small Generating Facility interconnects has established different requirements that apply to all similarly situated generators in the New York Control Area or Transmission District (as applicable) on a comparable basis, in accordance with Good Utility Practice.